1. Home
  2. TXG vs ADNT Comparison

TXG vs ADNT Comparison

Compare TXG & ADNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TXG
  • ADNT
  • Stock Information
  • Founded
  • TXG 2012
  • ADNT 2016
  • Country
  • TXG United States
  • ADNT Ireland
  • Employees
  • TXG N/A
  • ADNT N/A
  • Industry
  • TXG Biotechnology: Laboratory Analytical Instruments
  • ADNT Auto Parts:O.E.M.
  • Sector
  • TXG Industrials
  • ADNT Consumer Discretionary
  • Exchange
  • TXG Nasdaq
  • ADNT Nasdaq
  • Market Cap
  • TXG 1.6B
  • ADNT 1.9B
  • IPO Year
  • TXG 2019
  • ADNT N/A
  • Fundamental
  • Price
  • TXG $13.32
  • ADNT $23.89
  • Analyst Decision
  • TXG Buy
  • ADNT Hold
  • Analyst Count
  • TXG 12
  • ADNT 9
  • Target Price
  • TXG $13.54
  • ADNT $23.28
  • AVG Volume (30 Days)
  • TXG 2.8M
  • ADNT 774.7K
  • Earning Date
  • TXG 11-06-2025
  • ADNT 11-05-2025
  • Dividend Yield
  • TXG N/A
  • ADNT N/A
  • EPS Growth
  • TXG N/A
  • ADNT N/A
  • EPS
  • TXG N/A
  • ADNT N/A
  • Revenue
  • TXG $644,466,000.00
  • ADNT $14,409,000,000.00
  • Revenue This Year
  • TXG $2.11
  • ADNT $0.20
  • Revenue Next Year
  • TXG N/A
  • ADNT N/A
  • P/E Ratio
  • TXG N/A
  • ADNT N/A
  • Revenue Growth
  • TXG 2.02
  • ADNT N/A
  • 52 Week Low
  • TXG $6.78
  • ADNT $10.04
  • 52 Week High
  • TXG $18.21
  • ADNT $26.16
  • Technical
  • Relative Strength Index (RSI)
  • TXG 57.51
  • ADNT 51.70
  • Support Level
  • TXG $12.08
  • ADNT $22.56
  • Resistance Level
  • TXG $13.45
  • ADNT $23.84
  • Average True Range (ATR)
  • TXG 0.76
  • ADNT 0.83
  • MACD
  • TXG 0.18
  • ADNT -0.01
  • Stochastic Oscillator
  • TXG 95.82
  • ADNT 46.84

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

About ADNT Adient plc

Adient began trading Oct. 31, 2016, when Johnson Controls spun off its automotive experience segment. Adient is the leading seating supplier to the industry with about one third of the global market. Its share in China is now nearly 20%, down from about 45%, following the sale of its main joint venture there at the end of fiscal 2021. Unconsolidated revenue from joint ventures was about $3.8 billion in fiscal 2024 and consolidated China revenue was $1.4 billion. The company is headquartered in Ireland but has corporate offices in the Detroit area. Fiscal 2024 (Sept. 30 year-end) consolidated revenue, which excludes joint venture sales, was $14.7 billion and fiscal 2025 is guided to about $14.4 billion as foreign exchange helps offset some divested business.

Share on Social Networks: